Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)

The Journal of Biological Chemistry
G B WhitakerJ S Rosenbaum

Abstract

The two most abundant secreted isoforms of vascular endothelial growth factor A (VEGF(165) and VEGF(121)) are formed as a result of differential splicing of the VEGF-A gene. VEGF(165) and VEGF(121) share similar affinities at the isolated VEGF receptor (VEGFR)-2 but have been previously demonstrated to have differential ability to activate VEGFR-2-mediated effects on endothelial cells. Herein we investigate whether the recently described VEGF(165) isoform-specific receptor neuropilin-1 (Npn-1) is responsible for the difference in potency observed for these ligands. We demonstrate that although VEGFR-2 and Npn-1 form a complex, this complex does not result in an increase in VEGF(165) binding affinity. Therefore, the differential activity of VEGF(165) and VEGF(121) cannot be explained by a differential binding affinity for the complex. Using an antagonist that competes for VEGF(165) binding at the VEGFR-2.Npn-1 complex, we observe specific antagonism of VEGF(165)-meditated phosphorylation of VEGFR-2 without affecting the VEGF(121) response. These data indicate that the formation of the complex is responsible for the increased potency of VEGF(165) versus VEGF(121). Taken together, these data suggest a receptor-clustering role for ...Continue Reading

References

Oct 23, 1992·Science·T KishimotoT Taga
Aug 22, 1997·Cell·A L KolodkinD D Ginty
Aug 26, 1998·The Journal of Biological Chemistry·M MigdalG Neufeld
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·L De VriesM G Farquhar
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·L M WiseS A Stacker
Oct 16, 1999·Cell·T TakahashiS M Strittmatter
Nov 2, 1999·Journal of Molecular Biology·M A StarovasnikN J Skelton
Feb 19, 2000·Current Opinion in Neurobiology·J A Raper
Feb 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·M L GagnonM Klagsbrun
Mar 31, 2000·Nature Medicine·P Carmeliet
Apr 5, 2000·The Journal of Biological Chemistry·Z Gluzman-PoltorakG Neufeld
Jul 11, 2000·The Journal of Biological Chemistry·G FuhS S Sidhu
Dec 5, 2000·Current Opinion in Chemical Biology·L L KiesslingL E Strong
Dec 6, 2000·The Journal of Clinical Investigation·Y KasaharaN F Voelkel

❮ Previous
Next ❯

Citations

Feb 9, 2006·Cellular and Molecular Life Sciences : CMLS·S Cébe-SuarezK Ballmer-Hofer
Oct 12, 2012·Histochemistry and Cell Biology·Laura OlbrichCarsten Theiss
Apr 17, 2007·Annals of Biomedical Engineering·Feilim Mac GabhannAleksander S Popel
Nov 26, 2003·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohammad Atiqur Rahman, Masakazu Toi
Dec 17, 2005·Cancer Letters·Noga Guttmann-RavivGera Neufeld
Apr 15, 2004·Journal of Molecular and Cellular Cardiology·Katsuya AmanoHiroaki Matsubara
May 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y D JungL M Ellis
Feb 14, 2002·Trends in Cardiovascular Medicine·Gera NeufeldYael Herzog
Dec 14, 2011·Cell Research·Atsuko SakuraiJ Silvio Gutkind
Dec 7, 2007·Nature Neuroscience·Gang ChenXiao-Bing Yuan
Oct 20, 2009·The Journal of Biological Chemistry·Stephen D RobinsonKairbaan M Hodivala-Dilke
Aug 20, 2011·Hybridoma·Xiang LiJianghua Yan
Jan 10, 2008·Journal of the National Cancer Institute·Michael J GrayLee M Ellis
Dec 26, 2001·Current Opinion in Nephrology and Hypertension·Enyu Imai, Yoshitaka Isaka
Jul 27, 2002·Annual Review of Cell and Developmental Biology·Janet Rossant, Lorraine Howard
Jun 13, 2009·American Journal of Respiratory and Critical Care Medicine·Anne LePatrice M Becker
Aug 12, 2010·Journal of Angiogenesis Research·Steven P WilliamsSteven A Stacker
Dec 8, 2011·Endocrinology·Kyle C CairesDerek J McLean
Jan 2, 2007·PLoS Computational Biology·Feilim Mac Gabhann, Aleksander S Popel
Nov 13, 2008·Journal of Cardiovascular Medicine·Ugo TestaGian Luigi Condorelli
Dec 17, 2005·Proceedings of the National Academy of Sciences of the United States of America·Joon-Hwa LeeFiona Jucker
Nov 30, 2002·Expert Opinion on Investigational Drugs·Paul W ManleyJeanette M Wood
Jun 24, 2008·Endothelium : Journal of Endothelial Cell Research·Domenico Ribatti
Feb 11, 2003·Journal of Cellular Biochemistry·Mireille RossignolMichael Klagsbrun
Jan 15, 2015·ACS Nano·Vivek A KumarJeffrey D Hartgerink
Oct 19, 2004·Neuropathology and Applied Neurobiology·A BrockingtonP J Shaw

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.